CRP and cancer: In the multivariate analysis evaluating CRP, being female was associated with lower cancer mortality compared to being male in both the NHANES III (HR = 0.68, 95%CI: 0.54–0.87; p = 0.003) and the NHANES 1999–2002 (HR = 0.52, 95%CI: 0.27–0.99; p = 0.047) datasets (Table 3).